Lancet2: Improved and accelerated somatic variant calling with joint multi-sample local assembly graphs.
Summary
Lancet2 is an open-source somatic variant caller designed to enhance the detection of small variants in short-read sequencing data. It introduces significant improvements, including better variant discovery and genotyping through partial order multiple sequence alignment and read re-alignment. The tool also optimizes somatic variant scoring with explainable machine learning models and provides enhanced variant visualization. Benchmarking showed that Lancet2 outperformed other leading tools in variant calling performance, especially for InDels, while also demonstrating substantial speed improvements and reduced memory usage.
Analysis
Lancet2 represents a significant advancement for oncology research and precision medicine. Its ability to detect somatic variants more accurately and rapidly, especially insertions/deletions, is crucial for identifying genomic alterations that drive cancer development and progression. More reliable variant detection enables a deeper understanding of tumor biology, the identification of biomarkers, and the development of targeted therapies, thereby accelerating translational research and potentially clinical integration for more effective diagnostics and treatments.